| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.005 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
| mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.08 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.4 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.009 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |